{"id":"W1532468082","doi":"10.1111/j.1600-6143.2012.04031.x","title":"Alternative Immunomodulatory Strategies for Xenotransplantation: CD40/154 Pathway-Sparing Regimens Promote Xenograft Survival","year":2012,"lang":"en","type":"article","venue":"American Journal of Transplantation","topic":"Xenotransplantation and immune response","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta","funders":"National Institute of Allergy and Infectious Diseases; Teva Pharmaceutical Industries; National Center for Research Resources; Amgen","keywords":"Medicine; Xenotransplantation; Basiliximab; Belatacept; Immunosuppression; Transplantation; Calcineurin; Abatacept; Tolerability; Immunology; Oncology; Tacrolimus; Internal medicine; Rituximab; Adverse effect; Kidney transplantation","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008739167,0.0002877306,0.00062257,0.0003519137,0.0001499166,0.00005181782,0.0001595243,0.0000712901,0.00003630247],"category_scores_gemma":[0.00002213473,0.0002541243,0.0003232761,0.0003035979,0.0002012262,0.0009426362,0.000003354945,0.0003222278,0.00001038578],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009972019,"about_ca_system_score_gemma":0.0003547703,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007571486,"about_ca_topic_score_gemma":0.000009413378,"domain_scores_codex":[0.9977477,0.0002128312,0.0008530784,0.0001927721,0.0005234276,0.0004701476],"domain_scores_gemma":[0.9981369,0.0003068974,0.0007115466,0.0001847897,0.0003963519,0.0002634561],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.06037905,0.001854548,0.02847502,0.002364584,0.003248682,0.0004960157,0.08890863,0.002315064,0.72161,0.008495833,0.0001098832,0.08174269],"study_design_scores_gemma":[0.03617153,0.01730534,0.4159808,0.003828488,0.005880326,0.01642166,0.02675744,0.001429183,0.4631256,0.001241828,0.009456606,0.002401266],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8453352,0.0005401048,0.1521458,0.0002870106,0.000622955,0.0004573107,0.00008782776,0.00004071011,0.0004831104],"genre_scores_gemma":[0.9883576,0.001250665,0.009505915,0.0001922949,0.0004095744,0.00002222509,0.0001417752,0.00005276045,0.00006716199],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3875058,"threshold_uncertainty_score":0.9999911,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02283548916321968,"score_gpt":0.298719682971774,"score_spread":0.2758841938085543,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}